Literature DB >> 18679110

Tissue oxygenation during management of cerebral perfusion pressure with phenylephrine or vasopressin.

Michael Dudkiewicz1, Kenneth G Proctor.   

Abstract

OBJECTIVE: Phenylephrine is often used for management of cerebral perfusion pressure after traumatic brain injury, but can have undesirable actions. Few studies have evaluated alternatives. The hypothesis was that arginine vasopressin was as effective as phenylephrine for maintaining tissue oxygenation during cerebral perfusion pressure management.
DESIGN: Prospective randomized, blinded animal study.
SETTING: University laboratory.
SUBJECTS: Thirty-five anesthetized swine (46 +/- 1 kg).
INTERVENTIONS: Blunt trauma to the head and bilateral chests (estimated injury severity score was 25-32) was followed by hypoventilation. Resuscitation was divided into phases to simulate treatment in a typical prehospital, emergency room, and intensive care unit. For 30-45 mins postinjury, 1 L of normal saline was administered. For 45-120 mins, normal saline maintained systolic blood pressure >100 mm Hg plus mannitol for intracranial hypertension. After 120 mins, phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure >70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure >12 mm Hg plus glucose to maintain normoglycemia.
MEASUREMENTS AND MAIN RESULTS: Mortality rate was 37% (13 of 35) within 2 hrs. Before resuscitation, mean arterial pressure was 61 +/- 5 mm Hg, heart rate was 110 +/- 6 beats/min, PaO2 was 46 +/- 2 mm Hg, and lactate was 5.0 +/- 0.4 mM. Intracranial pressure increased from 8 +/- 1 mm Hg to 20 +/- 1 mm Hg and brain tissue PO2 decreased from 19 +/- 1 mm Hg to 8 +/- 1 mm Hg. Resuscitation corrected most variables, as well as mixed venous, renal, portal, and muscle oxygen saturations, but 90% (20 of 22) required pressor support. After 6 hrs with either pressor, hemodynamics were stable. However, with phenylephrine vs. arginine vasopressin, intracranial pressure averaged >10 mm Hg higher and brain tissue PO2 was 6 mm Hg lower, whereas tissue oxygen saturations were >10% higher in the shoulder and hindlimb muscles (all p < 0.05).
CONCLUSIONS: Arginine vasopressin was as effective as phenylephrine for maintaining cerebral perfusion pressure, but intracranial pressure and brain tissue oxygenation were improved at the expense of the periphery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18679110     DOI: 10.1097/CCM.0b013e3181847af3

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  13 in total

1.  Impact of low-dose vasopressin on trauma outcome: prospective randomized study.

Authors:  Stephen M Cohn; Janet McCarthy; Ronald M Stewart; Rachelle B Jonas; Daniel L Dent; Joel E Michalek
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

2.  Vasopressor use and effect on blood pressure after severe adult traumatic brain injury.

Authors:  Pimwan Sookplung; Arunotai Siriussawakul; Amin Malakouti; Deepak Sharma; Jin Wang; Michael J Souter; Randall M Chesnut; Monica S Vavilala
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

3.  Early cerebral perfusion pressure augmentation with phenylephrine after traumatic brain injury may be neuroprotective in a pediatric swine model.

Authors:  Stuart H Friess; Colin Smith; Todd J Kilbaugh; Suzanne G Frangos; Jill Ralston; Mark A Helfaer; Susan S Margulies
Journal:  Crit Care Med       Date:  2012-08       Impact factor: 7.598

4.  Use and effect of vasopressors after pediatric traumatic brain injury.

Authors:  Jane L Di Gennaro; Christopher D Mack; Amin Malakouti; Jerry J Zimmerman; William Armstead; Monica S Vavilala
Journal:  Dev Neurosci       Date:  2010-12-02       Impact factor: 2.984

5.  Hypertonic saline resuscitation enhances blood pressure recovery and decreases organ injury following hemorrhage in acute alcohol intoxicated rodents.

Authors:  Jesse K Sulzer; Annie M Whitaker; Patricia E Molina
Journal:  J Trauma Acute Care Surg       Date:  2013-01       Impact factor: 3.313

6.  Polynitroxylated pegylated hemoglobin: a novel neuroprotective hemoglobin for acute volume-limited fluid resuscitation after combined traumatic brain injury and hemorrhagic hypotension in mice.

Authors:  David K Shellington; Lina Du; Xianren Wu; Jennifer Exo; Vincent Vagni; Li Ma; Keri Janesko-Feldman; Robert S B Clark; Hülya Bayir; C Edward Dixon; Larry W Jenkins; Carleton J C Hsia; Patrick M Kochanek
Journal:  Crit Care Med       Date:  2011-03       Impact factor: 7.598

7.  Vasopressin in the pediatric cardiac intensive care unit: Myth or reality.

Authors:  Vishal K Singh; Rajesh Sharma; Amit Agrawal; Amit Varma
Journal:  Ann Pediatr Cardiol       Date:  2009-01

8.  The anesthetic effects on vasopressor modulation of cerebral blood flow in an immature swine model.

Authors:  Benjamin Bruins; Todd J Kilbaugh; Susan S Margulies; Stuart H Friess
Journal:  Anesth Analg       Date:  2013-03-04       Impact factor: 5.108

9.  Vasopressin ameliorates hypotension induced by beach chair positioning in a dose-dependent manner in patients undergoing arthroscopic shoulder surgery under general anesthesia.

Authors:  Soo Young Cho; Joungmin Kim; Sun Hong Park; Seongtae Jeong; Sung-Su Chung; Kyung Yeon Yoo
Journal:  Korean J Anesthesiol       Date:  2015-05-28

Review 10.  Cerebrovascular Response to Phenylephrine in Traumatic Brain Injury: A Scoping Systematic Review of the Human and Animal Literature.

Authors:  Logan Froese; Joshua Dian; Alwyn Gomez; Bertram Unger; Frederick A Zeiler
Journal:  Neurotrauma Rep       Date:  2020-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.